MYX

Flash News: OKX Wallet Now Integrated with Decentralized Perpetual Derivative Exchange MYX.Finance

Retrieved on: 
Wednesday, December 6, 2023
MYX, DEX, OKX, BTC, ETH, Web3, Cryptocurrency

SINGAPORE, Dec. 06, 2023 (GLOBE NEWSWIRE) -- OKX , a leading Web3 technology company, has issued updates for December 6, 2023.

Key Points: 
  • SINGAPORE, Dec. 06, 2023 (GLOBE NEWSWIRE) -- OKX , a leading Web3 technology company, has issued updates for December 6, 2023.
  • OKX Wallet is now integrated with MYX.Finance (MYX), a decentralized perpetual derivative exchange.
  • With this integration, OKX Wallet users can access the DEX via web extension.
  • MYX aims to provide traders with the ultimate derivative exchange experience, giving eligible users the ability to trade BTC and ETH perpetual swaps with up to 50x leverage.

OKX Ventures Announces Investment in Decentralized Perpetual Derivative Exchange MYX.Finance

Retrieved on: 
Tuesday, November 28, 2023
MYX, DEX, OKX, BTC, ETH, Digital, Growth, Cryptocurrency

SINGAPORE, Nov. 28, 2023 (GLOBE NEWSWIRE) -- OKX Ventures , the investment arm of leading crypto exchange and Web3 technology company OKX, today announced its investment in MYX.Finance (MYX), a decentralized perpetual derivative exchange.

Key Points: 
  • SINGAPORE, Nov. 28, 2023 (GLOBE NEWSWIRE) -- OKX Ventures , the investment arm of leading crypto exchange and Web3 technology company OKX, today announced its investment in MYX.Finance (MYX), a decentralized perpetual derivative exchange.
  • This investment is part of OKX Ventures' ongoing effort to enhance its growing portfolio of DEX projects.
  • With its efficient fund usage, MYX stands out as a highly scalable decentralized exchange in the market.
  • This announcement follows OKX Ventures' recent investment in Aark Digital , a decentralized derivative exchange built on Arbitrum.

Mithra’s NEXTSTELLIS® granted additional patent in the United States

Retrieved on: 
Tuesday, November 7, 2023
MITRA, ASX, Patent, Liver, United States Patent and Trademark Office, Tablet, 1836 U.S. Patent Office fire, Pregnancy, CET, Woman, Brussels Stock Exchange, Estetrol, MYX, Pharmaceutical industry, Birth control

Liege, Belgium, 07 November 2023 – 07:00 CET – Mithra (Euronext Brussels: MITRA), a company dedicated to Women’s Health, announces today that it has been granted an additional patent for NEXTSTELLIS® (3 mg drospirenone and 14.2 mg estetrol (E4) tablets) in the United States.

Key Points: 
  • Liege, Belgium, 07 November 2023 – 07:00 CET – Mithra (Euronext Brussels: MITRA), a company dedicated to Women’s Health, announces today that it has been granted an additional patent for NEXTSTELLIS® (3 mg drospirenone and 14.2 mg estetrol (E4) tablets) in the United States.
  • Granted by the United States Patent and Trademark Office, the new patent will provide NEXTSTELLIS® with oral-dosage-unit protection in the US market until 2036.
  • Mithra’s commercialization partner, Mayne Pharma Group Limited (ASX: MYX), holds the license and supply agreement for NEXTSTELLIS®/ESTELLE® in the United States since 2021.
  • David Horn Solomon, CEO of Mithra: “We are excited to have been granted this additional patent coverage for ESTELLE® under the trademark NEXTSTELLIS®, an oral contraceptive with a novel estrogen, in the United States.

TherapeuticsMD Announces Full Year 2022 Financial Results and Provides Update on Business Model Transition

Retrieved on: 
Friday, April 7, 2023
Professional Services, Health, Other Health, Finance, Asset Management, General Health, Pharmaceutical, MYX, Employment, Rubric, ASX, Hospira, Sale, Acquisition, Cryptocurrency, Bank

TherapeuticsMD, Inc. (“TherapeuticsMD” or the “Company”) (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results for the full year ended December 31, 2022.

Key Points: 
  • TherapeuticsMD, Inc. (“TherapeuticsMD” or the “Company”) (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results for the full year ended December 31, 2022.
  • “We look forward to continuing to streamline our operations as we complete the transition to a virtual business model that collects royalties from Mayne Pharma and our other licensees.
  • We also intend to explore other strategic pathways to create value for TherapeuticsMD shareholders,” said Mr. Walker.
  • The termination of certain members of the Company’s executive management team and all other employees was completed by December 31, 2022.

Dr. Reddy's Laboratories Announces Agreement to Acquire Mayne Pharma’s U.S. Generic Prescription Product Portfolio

Retrieved on: 
Monday, February 27, 2023
Biotechnology, Medical Devices, Health, Pharmaceutical, Cardiology, NYSE, ASX, USD, Erez Israeli, RDY, Acquisition, MYX, Patient, Hart–Scott–Rodino Antitrust Improvements Act, NSE, Laboratory, Calendar, Hospira, HSR, BSE, Pharmaceutical industry, IQVIA

Reddy’s”) today announced that it has entered into a definitive agreement to acquire the U.S. generic prescription product portfolio of Salisbury, Australia, based Mayne Pharma Group Limited (ASX: MYX).

Key Points: 
  • Reddy’s”) today announced that it has entered into a definitive agreement to acquire the U.S. generic prescription product portfolio of Salisbury, Australia, based Mayne Pharma Group Limited (ASX: MYX).
  • The portfolio includes approximately 45 commercial products, four pipeline products and 40 approved non-marketed products, including a number of generic products focused on women’s health.
  • For the financial period ended June 30, 2022, Mayne Pharma reported total revenue of $111 million (USD) for the acquired portfolio.
  • The portfolio of products acquired from Mayne Pharma is a strategic fit with our growth objectives.

Catalent to Acquire Metrics Contract Services for $475 Million to Expand High-Potent Capabilities and Oral Development and Manufacturing Capacity

Retrieved on: 
Tuesday, August 9, 2022
Chemicals, Plastics, Health, Manufacturing, General Health, Pharmaceutical, Biotechnology, Excipient, Drug Quality and Security Act, Hand, Industry, NYSE, R, CDMO, Phrase, CTLT, MYX, Failure, Growth, Technology, Securities Exchange Act of 1934, Information, Hospira, Consumer health laws, ASX, Patient, COVID-19, D, Acquisition, Securities Act of 1933, Goal, Contract, S&P, Metric, Health, Fine chemical, Catalent

The facilitys estimated annual production capacity exceeds one billion oral solid dose units.

Key Points: 
  • The facilitys estimated annual production capacity exceeds one billion oral solid dose units.
  • This acquisition will further expand Catalents ability to meet our customers expectations in fast-growing areas of the business and patient need.
  • Metrics Contract Services, a division of Mayne Pharma Group Limited, is a full-service pharmaceutical development and manufacturing organization serving clients worldwide delivering proven scientific and operational excellence for novel oral dosage forms.
  • Metrics provides formulation development, analytical testing and commercial manufacturing from its single-campus facility in Greenville, North Carolina.

MAYNE PHARMA AND GOODRX ANNOUNCE NEW INITIATIVE TO INCREASE AWARENESS OF NEXTSTELLIS® AND EXPAND ACCESS TO BIRTH CONTROL

Retrieved on: 
Friday, July 29, 2022
Acquisition, Education, HCPS, Awareness, IQVIA, Hospira, Learning, DTC, Estetrol, Birth, Woman, SEC, Risk, GoodRx, Private Securities Litigation Reform Act, ASX, Safety, Pregnancy, Prescription, Technology, DRSP, Patient, MYX, Reproductive health, Annual report, Program, Digital, Pharmaceutical industry, Birth control, Fine chemical

The collaborative initiative will deliver an enhanced direct-to-consumer program aimed at building awareness of NEXTSTELLIS (E4/DRSP) oral contraceptive availability in the United States.

Key Points: 
  • The collaborative initiative will deliver an enhanced direct-to-consumer program aimed at building awareness of NEXTSTELLIS (E4/DRSP) oral contraceptive availability in the United States.
  • In addition, the initiative is focused on improving access to and raising awareness of available birth control methods.
  • It will also build awareness among HCPs, over 4,000 of whom have already written prescriptions for the product.
  • Mayne Pharma's CEO Scott Richards said, "We are excited to announce this strategic agreement with GoodRx at a time when providing choice, education, and access to birth control has never been more critical.

GXO Supports Ecommerce Growth at The Beachbody Company’s MYXfitness

Retrieved on: 
Thursday, December 2, 2021
The Beachbody Company, MYX, Automation, Technology, Industry, NYSE, Exercise, Partnership, ESG, Twitter, GLOBE, CO2, Instagram, GXO, LinkedIn, Growth, YouTube, Warehouse, Renewable energy

MYXfitness is a leader in home exercise equipment, and were proud to partner with them, said Bill Fraine, GXO Chief Commercial Officer.

Key Points: 
  • MYXfitness is a leader in home exercise equipment, and were proud to partner with them, said Bill Fraine, GXO Chief Commercial Officer.
  • Were excited to be expanding our partnership with MYXfitness and to help the company meet its growth targets, said Mark Manduca, GXO Chief Investment Officer.
  • The addition of the Atlanta facility brings the companys total warehouse operations with GXO to more than 86,000 square feet.
  • GXO Logistics, Inc. (NYSE: GXO) is the worlds largest pure-play contract logistics provider in a $430 billion total addressable market that is benefitting from the rapid growth of ecommerce, automation and outsourcing.

Fifth Season of the Global Wellness Summit Podcast Features One-on-One Conversations with Summit Keynote Speakers, Wellness Icons, Authors, Designers & Disruptors

Retrieved on: 
Thursday, November 18, 2021
Food, Harvard University, Spontaneous, MD, Fitwell, Hope, Bloomberg, Centers for Disease Control and Prevention, Medical director, Artificial intelligence, Podcasts (software), New World School of the Arts, Ivy League, CEO, Workforce, Book, Health, Student, GWS, Center, Research, Columbia University, Encore Boston Harbor, Doug, Fortis Healthcare, Menopause, Accreditation, Education, Economic policy of the Barack Obama administration, Presidency of Barack Obama, MYX, Podcast, Technology, Industry, Connecticut Business Hall of Fame, Science, Nightclub, Interior design, Public relations, Pharmaceutical industry, Medicine

MIAMI, Nov. 18, 2021 /PRNewswire-PRWeb/ --The Global Wellness Summit (GWS) announces an exciting lineup of guests for the fifth season of the Global Wellness Summit Podcast, reflective of the 2021 Summit theme "A New New Era in Health & Wellness."

Key Points: 
  • MIAMI, Nov. 18, 2021 /PRNewswire-PRWeb/ --The Global Wellness Summit (GWS) announces an exciting lineup of guests for the fifth season of the Global Wellness Summit Podcast, reflective of the 2021 Summit theme "A New New Era in Health & Wellness."
  • The Global Wellness Summit Podcast is the leading wellness podcast dedicated to exploring the latest industry research and the real-world impact of evidence-backed wellness trends.
  • The episode is co-hosted by Veronica Schreibeis Smith, the wellness architect featured in Episode #34 and the Global Wellness Summit "2020 Leading Woman in Wellness."
  • About the Global Wellness Summit The Global Wellness Summit is the premier organization that brings together leaders and visionaries to positively shape the future of the $4.5 trillion global wellness economy.

Group Fitness Goes Digital: The Beachbody Company Launches “BODi”, A Live Connected Fitness Experience Unlike Anything on the Market

Retrieved on: 
Tuesday, October 19, 2021
Online Retail, Retail, Health, Other Retail, Fitness & Nutrition, Specialty, General Health, Yoga, LED, Bodi, Technology, Cooking, NYSE, BOD, Meditation, HIIT, CEO, Health, MYX, LLC, Music, Entertainment, Nightclub

The Beachbody Company Group, LLC (NYSE: BODY) a leader in subscription health and wellness announced the launch of its live interactive premium subscription tier, Beachbody On Demand Interactive (or BODi pronounced body).

Key Points: 
  • The Beachbody Company Group, LLC (NYSE: BODY) a leader in subscription health and wellness announced the launch of its live interactive premium subscription tier, Beachbody On Demand Interactive (or BODi pronounced body).
  • View the full release here: https://www.businesswire.com/news/home/20211019005463/en/
    The Beachbody Company launches BOD Interactive (BODi), offering the immersive, high energy experience of studio fitness classes with the convenience of at-home workouts.
  • Headquartered in Southern California, The Beachbody Company (NYSE: BODY) is a worldwide leading digital fitness and nutrition subscription company, with over two decades of creating innovative content and powerful brands.
  • The Beachbody Company is the parent company to the Beachbody On Demand streaming platform (BOD), the live digital streaming platform Openfit, and MYXfitness, the companys connected fitness brand.